Biothod is a privately held biotechnology company established in 2014. It was founded by the specialists with 10 years professional experience and know how in immunodiagnostics and clinical chemistry. Its activity is specialized in the R&D, manufacturing and distribution of immunoassay reagents and clinical chemistry reagents.

Today, we have already developed ready-to-use immunoassay reagents for the diagnosis, follow up and monitoring of treatment of thyroid, fertility, tumor markers, anaemia and infectious disease by means of different techniques.

Meanwhile, 42 clinical chemistry reagents for the diagnosis of liver function, renal function, lipid metabolism, carbohydrate metabolism, cardiac marker, specific proteins and pancreas function are available, as well. All these reagents can be running on any automated open system.

Biothod is also getting involved in the primary research work on instrumentation in the field of immunoassay and clinical chemistry with a leading European partner, which has more than 20 years experiences in in vitro diagnostics.

Our objectives are to manufacture the most effective reagents, to provide accessible technical support to ensure prompt and personal assistance in the use of these reagents, and to develop products which may bring significant advances.